Aura D Herrera-Martínez1,2, Manuel D Gahete1,3,4,5, Rafael Sánchez-Sánchez1,6, Emilia Alors-Perez1,3,4,5, Sergio Pedraza-Arevalo1,3,4,5, Raquel Serrano-Blanch1,7, Antonio J Martínez-Fuentes1,3,4,5, Maria A Gálvez-Moreno8,9, Justo P Castaño10,11,12,13, Raúl M Luque14,15,16,17. 1. Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. 2. Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain. 3. Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain. 4. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. 5. Reina Sofia University Hospital, Córdoba, Spain. 6. Pathology Service, Reina Sofia University Hospital, Córdoba, Spain. 7. Medical Oncology Service, Reina Sofia University Hospital, Córdoba, Spain. 8. Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. mariaa.galvez.sspa@juntadeandalucia.es. 9. Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain. mariaa.galvez.sspa@juntadeandalucia.es. 10. Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. justo@uco.es. 11. Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain. justo@uco.es. 12. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. justo@uco.es. 13. Reina Sofia University Hospital, Córdoba, Spain. justo@uco.es. 14. Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. raul.luque@uco.es. 15. Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain. raul.luque@uco.es. 16. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. raul.luque@uco.es. 17. Reina Sofia University Hospital, Córdoba, Spain. raul.luque@uco.es.
Abstract
OBJECTIVES: The association between the presence and alterations of the components of the ghrelin system and the development and progression of neuroendocrine tumors (NETs) is still controversial and remains unclear. METHODS: Here, we systematically evaluated the expression levels (by quantitative-PCR) of key ghrelin system components of in gastroenteropancreatic (GEP)-NETs, as compared to non-tumor adjacent (NTA; n = 42) and normal tissues (NT; n = 14). Then, we analyzed their putative associations with clinical-histological characteristics. RESULTS: The results indicate that ghrelin and its receptor GHSR1a are present in a high proportion of normal tissues, while the enzyme ghrelin-O-acyltransferase (GOAT) and the splicing variants In1-ghrelin and GHSR1b were present in a lower proportion of normal tissues. In contrast, all ghrelin system components were present in a high proportion of tumor and NTA tissues. GOAT was significantly overexpressed (by quantitative-PCR (qPCR)) in tumor samples compared to NTA, while a trend was found for ghrelin, In1-ghrelin and GHSR1a. In addition, expression of these components displayed significant correlations with key clinical parameters. The marked overexpression of GOAT in tumor samples compared to NTA regions was confirmed by IHC, revealing that this enzyme is particularly overexpressed in gastrointestinal NETs, where it is directly correlated with tumor diameter. CONCLUSIONS: These results provide novel information on the presence and potential pathophysiological implications of the ghrelin system components in GEP-NETs, wherein GOAT might represent a novel diagnostic biomarker.
OBJECTIVES: The association between the presence and alterations of the components of the ghrelin system and the development and progression of neuroendocrine tumors (NETs) is still controversial and remains unclear. METHODS: Here, we systematically evaluated the expression levels (by quantitative-PCR) of key ghrelin system components of in gastroenteropancreatic (GEP)-NETs, as compared to non-tumor adjacent (NTA; n = 42) and normal tissues (NT; n = 14). Then, we analyzed their putative associations with clinical-histological characteristics. RESULTS: The results indicate that ghrelin and its receptor GHSR1a are present in a high proportion of normal tissues, while the enzyme ghrelin-O-acyltransferase (GOAT) and the splicing variants In1-ghrelin and GHSR1b were present in a lower proportion of normal tissues. In contrast, all ghrelin system components were present in a high proportion of tumor and NTA tissues. GOAT was significantly overexpressed (by quantitative-PCR (qPCR)) in tumor samples compared to NTA, while a trend was found for ghrelin, In1-ghrelin and GHSR1a. In addition, expression of these components displayed significant correlations with key clinical parameters. The marked overexpression of GOAT in tumor samples compared to NTA regions was confirmed by IHC, revealing that this enzyme is particularly overexpressed in gastrointestinal NETs, where it is directly correlated with tumor diameter. CONCLUSIONS: These results provide novel information on the presence and potential pathophysiological implications of the ghrelin system components in GEP-NETs, wherein GOAT might represent a novel diagnostic biomarker.
Authors: Raul M Luque; Manuel D Gahete; Ute Hochgeschwender; Rhonda D Kineman Journal: Am J Physiol Endocrinol Metab Date: 2006-08 Impact factor: 4.310
Authors: J P Castaño; A Sundin; H R Maecke; C Villabona; R Vazquez-Albertino; E Navarro; K Oberg Journal: Cancer Metastasis Rev Date: 2014-03 Impact factor: 9.264
Authors: J Capdevila; O Casanovas; R Salazar; D Castellano; A Segura; P Fuster; J Aller; R García-Carbonero; P Jimenez-Fonseca; E Grande; J P Castaño Journal: Oncogene Date: 2016-09-19 Impact factor: 9.867
Authors: R Garcia-Carbonero; J Capdevila; G Crespo-Herrero; J A Díaz-Pérez; M P Martínez Del Prado; V Alonso Orduña; I Sevilla-García; C Villabona-Artero; A Beguiristain-Gómez; M Llanos-Muñoz; M Marazuela; C Alvarez-Escola; D Castellano; E Vilar; P Jiménez-Fonseca; A Teulé; J Sastre-Valera; M Benavent-Viñuelas; A Monleon; R Salazar Journal: Ann Oncol Date: 2010-02-05 Impact factor: 32.976
Authors: G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann Journal: Virchows Arch Date: 2006-09-12 Impact factor: 4.064
Authors: Alejandro Ibáñez-Costa; Manuel D Gahete; Esther Rivero-Cortés; David Rincón-Fernández; Richard Nelson; Manuel Beltrán; Andrés de la Riva; Miguel A Japón; Eva Venegas-Moreno; Ma Ángeles Gálvez; Juan A García-Arnés; Alfonso Soto-Moreno; Jennifer Morgan; Natia Tsomaia; Michael D Culler; Carlos Dieguez; Justo P Castaño; Raúl M Luque Journal: Sci Rep Date: 2015-03-04 Impact factor: 4.379
Authors: Yiraldine Herrera-Martínez; Carlos Alzas Teomiro; Soraya León Idougourram; María José Molina Puertas; Alfonso Calañas Continente; Raquel Serrano Blanch; Justo P Castaño; María Ángeles Gálvez Moreno; Manuel D Gahete; Raúl M Luque; Aura D Herrera-Martínez Journal: Cancers (Basel) Date: 2021-12-27 Impact factor: 6.639